Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 14 studies | 38% ± 16% | |
retinal cone cell | 7 studies | 35% ± 12% | |
GABAergic neuron | 7 studies | 41% ± 16% | |
glutamatergic neuron | 7 studies | 42% ± 19% | |
interneuron | 6 studies | 34% ± 8% | |
astrocyte | 5 studies | 25% ± 9% | |
neuron | 5 studies | 46% ± 13% | |
GABAergic interneuron | 3 studies | 33% ± 19% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 8% | |
retinal ganglion cell | 3 studies | 27% ± 1% | |
neural progenitor cell | 3 studies | 19% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 32% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 7218.45 | 2639 / 2642 | 99% | 54.18 | 699 / 705 |
adrenal gland | 4% | 32.93 | 11 / 258 | 57% | 11.10 | 131 / 230 |
uterus | 0% | 0 | 0 / 170 | 14% | 3.62 | 64 / 459 |
ovary | 0% | 0 | 0 / 180 | 11% | 3.14 | 49 / 430 |
tonsil | 0% | 0 | 0 / 0 | 9% | 1.32 | 4 / 45 |
breast | 0% | 0 | 0 / 459 | 5% | 1.11 | 59 / 1118 |
skin | 0% | 0.63 | 2 / 1809 | 4% | 0.48 | 21 / 472 |
lung | 0% | 0 | 0 / 578 | 4% | 0.90 | 43 / 1155 |
bladder | 0% | 0 | 0 / 21 | 3% | 1.16 | 16 / 504 |
intestine | 2% | 10.51 | 18 / 966 | 1% | 0.14 | 6 / 527 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.27 | 26 / 901 |
esophagus | 0% | 0.31 | 1 / 1445 | 3% | 0.15 | 5 / 183 |
eye | 0% | 0 | 0 / 0 | 3% | 0.47 | 2 / 80 |
stomach | 0% | 1.23 | 1 / 359 | 2% | 0.46 | 6 / 286 |
prostate | 0% | 2.71 | 1 / 245 | 1% | 0.05 | 5 / 502 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.61 | 2 / 178 |
liver | 0% | 0 | 0 / 226 | 1% | 0.08 | 4 / 406 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.07 | 1 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0050774 | Biological process | negative regulation of dendrite morphogenesis |
GO_0007399 | Biological process | nervous system development |
GO_0006208 | Biological process | pyrimidine nucleobase catabolic process |
GO_0007411 | Biological process | axon guidance |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0030425 | Cellular component | dendrite |
GO_0043025 | Cellular component | neuronal cell body |
GO_0004157 | Molecular function | dihydropyrimidinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016812 | Molecular function | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides |
Gene name | DPYSL5 |
Protein name | Uncharacterized protein DPYSL5 Dihydropyrimidinase like 5 Dihydropyrimidinase-related protein 5 (DRP-5) (CRMP3-associated molecule) (CRAM) (Collapsin response mediator protein 5) (CRMP-5) (UNC33-like phosphoprotein 6) (ULIP-6) |
Synonyms | ULIP6 CRMP5 |
Description | FUNCTION: Involved in the negative regulation of dendrite outgrowth. . |
Accessions | ENST00000288699.11 ENST00000450961.5 ENST00000614712.4 ENST00000434719.1 Q53SW3 ENST00000431402.5 E7ESV0 Q53T73 E9PHT0 ENST00000401478.5 E7EWB4 Q9BPU6 |